Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bexsero

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Invasive meningococcal disease (IMD), caused by Neisseria meningitidis (Nm) strains, is a life-threatening but vaccine… Expand
2019
2019
Invasive meningococcal disease (IMD) is associated with a high mortality and severe sequelae. The aim of the present study was to… Expand
Review
2017
Review
2017
ABSTRACT Vaccines often require adjuvants to be effective. Traditional adjuvants, like alum, activate the immune response but in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
The crystal structures and functional characterization of two anti-NHBA human Fabs provide insight into the recognition by human… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
2016
2016
Bexsero, a new vaccine against serogroup B meningococcal disease (MenB), was licensed in Europe in January 2013. In Germany… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Review
2016
Review
2016
Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults… Expand
  • table 2
Review
2015
Review
2015
Summary Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by… Expand
  • figure 1
  • figure 2
Review
2015
Review
2015
Summary A century of traditional vaccinology lost the fight against meningococcus serogroup B (MenB). However, thanks to an… Expand
Review
2015
Review
2015
Neisseria meningitidis infections are a major public health problem worldwide. Although conventional approaches have not led to… Expand
2014
2014
Meningococcal disease is a major cause of morbidity and mortality worldwide. Its epidemiology is currently dominated by five… Expand
  • table 1
  • table 2
  • figure 1